Panagiota Tsiri

Patra, ESYE23 26504, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Pulmonary Fibrosis Beyond the Lung: Adipose Tissue as a Systemic Modifier of Fibrotic Remodeling.

Pulmonary Fibrosis Beyond the Lung: Adipose Tissue as a Systemic Modifier of Fibrotic Remodeling.

Journal: Diagnostics (Basel, Switzerland)

Published: March 25, 2026

Lipidemic Profile of Patients with Non-Small Cell Lung Cancer and Its Association with Driver Mutations: A Tertiary Center Retrospective Study.

Lipidemic Profile of Patients with Non-Small Cell Lung Cancer and Its Association with Driver Mutations: A Tertiary Center Retrospective Study.

Journal: Cancers

Published: December 18, 2025

The Fibrotic-Cancer Continuum in IPF: Shared Mechanisms, Clinical Implications and Therapeutic Challenges.

The Fibrotic-Cancer Continuum in IPF: Shared Mechanisms, Clinical Implications and Therapeutic Challenges.

Journal: Life (Basel, Switzerland)

Published: November 13, 2025

Intravenous Immunoglobulin in Acute Exacerbations of Fibrotic Interstitial Lung Diseases: A Retrospective, Real-World Study.

Intravenous Immunoglobulin in Acute Exacerbations of Fibrotic Interstitial Lung Diseases: A Retrospective, Real-World Study.

Journal: Medicina (Kaunas, Lithuania)

Published: July 30, 2025

Geographical Inequalities and Comorbidities in the Timely Diagnosis of NSCLC: A Real-Life Retrospective Study from a Tertiary Hospital in Western Greece.

Geographical Inequalities and Comorbidities in the Timely Diagnosis of NSCLC: A Real-Life Retrospective Study from a Tertiary Hospital in Western Greece.

Journal: Cancers

Published: July 27, 2025

Clinical trials on acute exacerbations of interstitial lung diseases.

Clinical trials on acute exacerbations of interstitial lung diseases.

Journal: Expert review of respiratory medicine

Published: June 17, 2025

Building translational bridges in idiopathic pulmonary fibrosis research: from epithelial dysfunction to dysregulated macrophage polarisation and fibrogenesis.

Building translational bridges in idiopathic pulmonary fibrosis research: from epithelial dysfunction to dysregulated macrophage polarisation and fibrogenesis.

Journal: The European respiratory journal

Published: May 04, 2025

Rejuvenation as a future for pulmonary fibrosis.

Rejuvenation as a future for pulmonary fibrosis.

Journal: The European respiratory journal

Published: March 30, 2025

Real-World Evidence of Administration of Biologic Agents in Patients with Severe Asthma: An Analysis of the Respiratory Department of University Hospital of Patras Asthma Registry.

Real-World Evidence of Administration of Biologic Agents in Patients with Severe Asthma: An Analysis of the Respiratory Department of University Hospital of Patras Asthma Registry.

Journal: Journal of clinical medicine

Published: March 11, 2025

Complete Blood Cell Count Parameters Predict Mortality in Patients with Hypersensitivity Pneumonitis.

Complete Blood Cell Count Parameters Predict Mortality in Patients with Hypersensitivity Pneumonitis.

Journal: Diagnostics (Basel, Switzerland)

Published: March 07, 2025

Biologic Agents in Idiopathic Hypereosinophilic Syndrome.

Biologic Agents in Idiopathic Hypereosinophilic Syndrome.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 06, 2025

A new era in the treatment of progressive fibrosing interstitial lung diseases.

A new era in the treatment of progressive fibrosing interstitial lung diseases.

Journal: Breathe (Sheffield, England)

Published: December 02, 2024

Showing 1-12 of 22

Last Updated: 09/26/2026